115698-86-7Relevant articles and documents
Unusual enantioselectivities in heterogeneous organocatalyzed reactions: Reversal of direction using proline di- versus tri-peptides in the aldol addition
Szollosi, Gy?rgy,Csámpai, Antal,Somlai, Csaba,Fekete, Mónika,Bartók, Mihály
, p. 86 - 92 (2014)
The heterogeneous asymmetric direct aldol reactions between aldehydes (2-nitrobenzaldehyde, 2-methylpropanal) and ketones (acetone, cyclohexanone) in the presence of polystyrene (PS) resin supported di- and tripeptides were studied under otherwise identic
Reversal of the enantioselectivity in aldol addition over immobilized di- and tripeptides: Studies under continuous flow conditions
Gurka, Andrs,Bucsi, Imre,Kovcs, Lenke,Szollosi, Gy?rgy,Bartk, Mihly
, p. 61611 - 61618 (2014)
Heterogeneous asymmetric direct aldol reactions between aldehydes (2-nitrobenzaldehyde, 2-methylpropanal) and acetone catalyzed by polystyrene resin (PS) supported di- and tripeptides H-Pro-Pro-, H-Pro-Pro-Pro-, H-Pro-Glu(OH)-, H-Pro-Pro-Glu(OH)-, H-Pro-Asp(OH)-, H-Pro-Pro-Asp(OH)-, H-Ser-Glu(OH)-, H-Ser-Ser-Glu(OH)-, H-Val-Glu(OH)-, H-Val-Val-Glu(OH)-MBHA-PS, were studied under identical experimental conditions at room temperature in a continuous-flow fixed-bed reactor (CFBR) system. In the asymmetric aldol reactions reversal of enantioselectivity was observed on H-Pro-Pro-Glu(OH)- and H-Pro-Pro-Asp(OH)-MBHA-PS-supported catalysts (ee 42-67% S) as compared to the H-Pro-Glu(OH)- and H-Pro-Asp(OH)-MBHA-PS-supported catalyst (ee 28-82% R). In the case of H-Pro-Pro- and H-Pro-Pro-Pro-MBHA-PS-supported catalysts reversed enantioselectivity was observed by using the benzoic acid additive (12% S) as compared to the H-Pro-MBHA-PS catalyst (25% R). The stability of the catalysts in the flow system was consistent with the heterogeneous character of the reaction, as was the linear behavior obtained using mixtures of l- and d-enantiomers of the supported H-Pro-MBHA-PS catalyst. The enamine character of the reaction intermediates was supported by ESI-MS measurements. Based on these and the computed structure of the peptides, the conformation of the intermediate adducts is held responsible for chiral induction, therefore for the enantioselectivity inversion observed in these reactions.
Organocatalytic diastereo- And enantioselective oxa-hetero-Diels-Alder reactions of enones with aryl trifluoromethyl ketones for the synthesis of trifluoromethyl-substituted tetrahydropyrans
Pasha, Maira,Tanaka, Fujie
supporting information, p. 9242 - 9250 (2021/11/16)
Tetrahydropyran derivatives are found in bioactives, and introduction of the trifluoromethyl group into molecules often improves biofunctions. Here we report diastereo- and enantioselective oxa-hetero-Diels-Alder reactions catalyzed by amine-based catalyst systems that afford trifluoromethyl-substituted tetrahydropyranones. Catalyst systems and conditions suitable for the reactions to provide the desired diastereomer products with high enantioselectivities were identified, and various trifluoromethyl-substituted tetrahydropyranones were synthesized with high diastereo- and enantioselectivities. Mechanistic investigation suggested that the reactions involve a [4 + 2] cycloaddition pathway, in which the enamine of the enone acts as the diene and the ketone carbonyl group of the aryl trifluoromethyl ketone acts as the dienophile. In this study, tetrahydropyran derivatives with the desired stereochemistry that are difficult to synthesize by previously reported methods were concisely obtained, and the range of tetrahydropyran derivatives that can be synthesized was expanded. This journal is
Dopamine D2 receptor selective agonist and application thereof
-
Paragraph 0193-0194, (2020/12/29)
The invention relates to a dopamine D2 receptor selective agonist and application thereof. Specifically, the invention discloses an agonist with selectivity to DRD2 and discloses a potential application value of the agonist in disease treatment. The invention discloses an agonist with DRD2 selectivity for the first time, and the specific targeting DRD2 of the agonist can play a role in treating low dopamine related diseases such as Parkinson's disease, attention deficit hyperactivity disorder, pituitary adenoma, hyperprolactinemia, hyperactivity leg syndrome, negative schizophrenia and the like while side effects are reduced to the maximum extent.
Continuous Flow Synthesis of Quinolines via a Scalable Tandem Photoisomerization-Cyclization Process
Di Filippo, Mara,Baumann, Marcus
, p. 6199 - 6211 (2020/08/26)
A continuous photochemical process is presented that renders a series of quinoline products via an alkene isomerization and cyclocondensation cascade. It is demonstrated that a high-power LED lamp generates the desired targets with higher productivity and efficiency than a medium-pressure Hg-lamp. The scope of this tandem process is established and allows for the generation of various substituted quinolines in high yields and with throughputs of greater than one gram per hour. Finally, this effective flow process is coupled with a telescoped hydrogenation reaction to render a series of tetrahydroquinolines including the antimalarial natural product galipinine.
